Skip Navigation

A Phase II Trial of sEphB4-HSA in Combination with Anti PD1 Antibody Pembrolizumab, MK-3475 for Solid Tumors

Brief Summary

Type:
Urologic / Genitourinary - Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT02717156

Study #:
STUDY00143871

Start Date:
Oct 01, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02717156

View Complete Trial Details & Eligibility at ClinicalTrials.gov